Pfizer, for the third time, has failed to get sildenafil [`Viagra'] listed under Australia's PBS,

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.353, 2002-01, pp. : 11-11

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pfizer's sildenafil appeal rejected in Australia

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 257, 2000-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

The federal government in Australia has announced that Pfizer's atorvastatin [Lipitor] warrants a higher price than Merck & Co's simvastatin [Zocor] for Pharmaceutical Benefits Scheme (PBS) subsidy

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 483, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Pfizer says NAION not increased with Viagra

Inpharma, Vol. 1, Iss. 1491, 2005-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Since Novartis' COX-2 inhibitor lumiracoxib [`Prexige'] has failed to demonstrate features differentiating it from the class leader celecoxib [`Celebrex; Pfizer/Pharmacia'], it could have limited market success

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 403, 2003-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Sildenafil [`Viagra'] is effective in the treatment of antidepressant-induced sexual dysfunction in women

Inpharma, Vol. 1, Iss. 1238, 2000-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite